Department of Public Health · University of Basel

Research

Public Health is the science and art of preventing disease, prolonging life and promoting health through the organized efforts and informed choices of society, organizations, public and private, communities and individuals. It involves many disciplines which share health care system approach, and focus on entire populations rather than individual patients alone. Furthermore, disciplines involved in public health share strengths in a variety of methodological approaches (quantitative (epidemiologic, health economic, qualitative, mixed methods research & implementation science).

DPH Project Funding 2017

Highlights current projects

SNF funding

INTERCARE (Implementation of an Integrated Community-based Care Program for Senior Citizens)
INTERCARE is an implementation science research project, which combines qualitative and quantitative methods to explore implementation processes and assesses the effectiveness of a new model of care. It addresses several key issues of the healthcare system in Switzerland including the development and assessment of new care models, interprofessional collaboration and the quality of care in nursing homes.

SAPALDIA (Swiss study on Air Pollution And Lung Disease in Adults)
The only Swiss-wide chronic disease cohort with associated biobank. It was initiated in 1991 and has since been funded by the SNF, the Federal Offices for the Environment and Public Health, different Lung Leagues and cantons. SAPALDIA is at the center of national and international air pollution (FP7 Projects ESCAPE; Exposomics) and respiratory health research (Horizon2020 Project: ALEC). The rich risk factor, environmental and health data as well as the genome- and methylome-wide data is used in studies ranging from assessing the role of physical activity, sleep, and transportation noise in cardio-metabolic disease etiology to the evaluation of chronic disease diagnosis and treatment as well as aging in general

EU funding

HBM4EU (coordinating and advancing human biomonitoring in europe to provide evidence for chemical policy making)
is a joint effort of 28 countries, the European Environment Agency and the European Commission, co-funded under Horizon 2020 with more than 70 Mio. Euro. The main aim of the initiative is to coordinate and advance human biomonitoring in Europe.

OPERAM (Optimising PharmacothERApy in the Multimorbid elderly)
Many older adults have multiple chronic diseases (multi-morbidity) and multiple medications (polypharmacy). However, multi-morbid patients are often excluded from clinical trials and most guidelines address diseases in isolation. OPERAM investigators developed STOPP/START criteria to detect inappropriate drug use, both over- and underuse. OPERAM performs a multicentre randomised controlled trial to assess the impact of a user-friendly software-assisted intervention to optimise pharmacotherapy and to enhance compliance in 1900 multi-morbid patients aged 75 years or older. OPERAM ultimately aims at better healthcare delivery in primary and hospital care, based on effective, safe, personalised and cost-effective interventions that can be applied to the rapidly growing older population in Europe. Within OPERAM, ECPM is responsible for the work package devoted to health economics.